mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |